Inozyme Pharma Inc (INZY)
2.72
-0.07
(-2.51%)
USD |
NASDAQ |
Nov 21, 15:10
Inozyme Pharma Price: 2.72 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 2.79 | 2.878 | 2.69 | 2.79 | 393295.0 |
| Nov 19, 2024 | 2.88 | 2.95 | 2.75 | 2.81 | 652897.0 |
| Nov 18, 2024 | 3.10 | 3.205 | 2.87 | 2.88 | 438704.0 |
| Nov 15, 2024 | 3.48 | 3.48 | 3.08 | 3.125 | 474396.0 |
| Nov 14, 2024 | 3.59 | 3.595 | 3.41 | 3.43 | 321544.0 |
| Nov 13, 2024 | 3.81 | 3.82 | 3.50 | 3.55 | 284635.0 |
| Nov 12, 2024 | 3.99 | 3.99 | 3.695 | 3.76 | 258501.0 |
| Nov 11, 2024 | 4.04 | 4.095 | 3.96 | 4.00 | 244492.0 |
| Nov 08, 2024 | 4.09 | 4.132 | 3.98 | 4.02 | 322995.0 |
| Nov 07, 2024 | 4.23 | 4.365 | 4.10 | 4.10 | 517111.0 |
| Nov 06, 2024 | 4.40 | 4.45 | 4.20 | 4.23 | 630439.0 |
| Nov 05, 2024 | 4.39 | 4.455 | 4.02 | 4.07 | 419782.0 |
| Nov 04, 2024 | 4.37 | 4.742 | 4.37 | 4.42 | 233931.0 |
| Nov 01, 2024 | 4.34 | 4.42 | 4.21 | 4.36 | 261952.0 |
| Oct 31, 2024 | 4.56 | 4.56 | 4.28 | 4.29 | 262980.0 |
| Oct 30, 2024 | 4.61 | 4.78 | 4.50 | 4.54 | 171015.0 |
| Oct 29, 2024 | 4.75 | 4.78 | 4.52 | 4.62 | 243479.0 |
| Oct 28, 2024 | 4.79 | 4.90 | 4.73 | 4.78 | 245265.0 |
| Oct 25, 2024 | 4.96 | 5.105 | 4.760 | 4.79 | 189896.0 |
| Oct 24, 2024 | 4.94 | 5.16 | 4.78 | 4.91 | 487030.0 |
| Oct 23, 2024 | 5.10 | 5.17 | 4.81 | 4.90 | 257520.0 |
| Oct 22, 2024 | 5.27 | 5.275 | 5.01 | 5.11 | 267326.0 |
| Oct 21, 2024 | 5.48 | 5.59 | 5.28 | 5.28 | 172250.0 |
| Oct 18, 2024 | 5.18 | 5.55 | 5.17 | 5.54 | 206862.0 |
| Oct 17, 2024 | 5.31 | 5.32 | 5.125 | 5.15 | 215221.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.05
Minimum
Dec 30 2022
30.20
Maximum
Sep 01 2020
9.077
Average
5.45
Median
Jul 19 2022
Price Benchmarks
| Tango Therapeutics Inc | 3.655 |
| CEL-SCI Corp | 0.6075 |
| AIM ImmunoTech Inc | 0.2116 |
| IGC Pharma Inc | 0.3496 |
| NovaBay Pharmaceuticals Inc | 0.70 |
Price Related Metrics
| Price to Book Value | 2.111 |
| Earnings Yield | -57.35% |
| Market Cap | 174.73M |